关注
Marc H. Scheetz
Marc H. Scheetz
Professor of Pharmacy and Pharmacology, Midwestern University, Colleges of Pharmacy and Graduate
在 midwestern.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of …
AK Taylor, TR Zembower, RB Nadler, MH Scheetz, JP Cashy, D Bowen, ...
The Journal of urology 187 (4), 1275-1279, 2012
3132012
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy
SM Trifilio, CL Bennett, PR Yarnold, JM McKoy, J Parada, J Mehta, ...
Bone marrow transplantation 39 (7), 425-429, 2007
2522007
Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae
M McLaughlin, MR Advincula, M Malczynski, C Qi, M Bolon, MH Scheetz
Antimicrobial agents and chemotherapy 57 (10), 5131-5133, 2013
2072013
Effects on patient care caused by drug shortages: a survey
M McLaughlin, D Kotis, K Thomson, M Harrison, G Fennessy, ...
Journal of Managed Care Pharmacy 19 (9), 783-788, 2013
1742013
Vancomycin area under the curve and acute kidney injury: a meta-analysis
DM Aljefri, SN Avedissian, NJ Rhodes, MJ Postelnick, K Nguyen, ...
Clinical Infectious Diseases 69 (11), 1881-1887, 2019
1582019
The emperor’s new clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with …
TP Lodise Jr, SL Rosenkranz, M Finnemeyer, S Evans, M Sims, ...
Clinical Infectious Diseases 70 (8), 1536-1545, 2020
1352020
In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii
MH Scheetz, C Qi, JR Warren, MJ Postelnick, T Zembower, A Obias, ...
Antimicrobial agents and chemotherapy 51 (5), 1621-1626, 2007
1352007
Antimicrobial stewardship programs: methods of operation and suggested outcomes
M Griffith, M Postelnick, M Scheetz
Expert review of anti-infective therapy 10 (1), 63-73, 2012
1172012
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections
JS Esterly, M Griffith, C Qi, M Malczynski, MJ Postelnick, MH Scheetz
Antimicrobial agents and chemotherapy 55 (10), 4844-4849, 2011
1132011
The effect of time to antifungal therapy on mortality in Candidemia associated septic shock
GP Patel, D Simon, M Scheetz, CW Crank, T Lodise, N Patel
American journal of therapeutics 16 (6), 508-511, 2009
1112009
Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption
MH Scheetz, SA Knechtel, M Malczynski, MJ Postelnick, C Qi
Antimicrobial agents and chemotherapy 52 (6), 2256-2259, 2008
1042008
Characterization of Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Clinical Strains Collected from 2004 to 2007
C Qi, M Malczynski, M Parker, MH Scheetz
Journal of clinical microbiology 46 (3), 1106-1109, 2008
1042008
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification
JS Esterly, J Wagner, MM McLaughlin, MJ Postelnick, C Qi, MH Scheetz
Antimicrobial agents and chemotherapy 56 (9), 4885-4890, 2012
992012
Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonellamodel and a pilot study …
MM McLaughlin, MR Advincula, M Malczynski, G Barajas, C Qi, ...
BMC infectious diseases 14, 1-10, 2014
952014
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
MF Konig, AHJ Kim, MH Scheetz, ER Graef, JW Liew, J Simard, ...
Annals of the rheumatic diseases 79 (10), 1386-1388, 2020
942020
Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials
JA Justo, TP Gauthier, MH Scheetz, EB Chahine, PB Bookstaver, ...
Clinical Infectious Diseases 59 (suppl_3), S162-S169, 2014
942014
Bacterial and clinical characteristics of health care-and community-acquired bloodstream infections due to Pseudomonas aeruginosa
A Hattemer, A Hauser, M Diaz, M Scheetz, N Shah, JP Allen, ...
Antimicrobial agents and chemotherapy 57 (8), 3969-3975, 2013
882013
A review of the clinical pharmacokinetics of polymyxin B
SN Avedissian, J Liu, NJ Rhodes, A Lee, GM Pais, AR Hauser, ...
Antibiotics 8 (1), 31, 2019
872019
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections
SN Rao, NJ Rhodes, BJ Lee, MH Scheetz, AP Hanson, J Segreti, ...
Antimicrobial agents and chemotherapy 59 (9), 5232-5238, 2015
872015
Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin‐Resistant Staphylococcus aureus Pneumonia
MH Scheetz, RG Wunderink, MJ Postelnick, GA Noskin
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (4 …, 2006
852006
系统目前无法执行此操作,请稍后再试。
文章 1–20